205 related articles for article (PubMed ID: 8784073)
1. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
3. Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites.
Chegini N; Zhao Y; Williams RS; Flanders KC
Endocrinology; 1994 Jul; 135(1):439-49. PubMed ID: 8013382
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
[TBL] [Abstract][Full Text] [Related]
5. Human fallopian tube expresses transforming growth factor (TGF beta) isoforms, TGF beta type I-III receptor messenger ribonucleic acid and protein, and contains [125I]TGF beta-binding sites.
Zhao Y; Chegini N; Flanders KC
J Clin Endocrinol Metab; 1994 Oct; 79(4):1177-84. PubMed ID: 7962292
[TBL] [Abstract][Full Text] [Related]
6. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Luo X; Ding L; Ripley D
Mol Cell Endocrinol; 2003 Nov; 209(1-2):9-16. PubMed ID: 14604812
[TBL] [Abstract][Full Text] [Related]
7. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
9. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.
Harrison-Woolrych ML; Sharkey AM; Charnock-Jones DS; Smith SK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1853-8. PubMed ID: 7775632
[TBL] [Abstract][Full Text] [Related]
10. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
Harrison-Woolrych ML; Charnock-Jones DS; Smith SK
J Clin Endocrinol Metab; 1994 May; 78(5):1179-84. PubMed ID: 8175976
[TBL] [Abstract][Full Text] [Related]
11. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
12. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
14. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
Chegini N; Tang XM; Ma C
J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
[TBL] [Abstract][Full Text] [Related]
15. The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro.
Tang XM; Dou Q; Zhao Y; McLean F; Davis J; Chegini N
Mol Hum Reprod; 1997 Mar; 3(3):233-40. PubMed ID: 9237249
[TBL] [Abstract][Full Text] [Related]
16. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
[TBL] [Abstract][Full Text] [Related]
17. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
18. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
[TBL] [Abstract][Full Text] [Related]
19. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells.
Luo X; Xu J; Chegini N
Reprod Biol Endocrinol; 2003 Dec; 1():125. PubMed ID: 14678567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
